Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind 12-week study of LY2599506 in adults with type 2 diabetes mellitus
2009-014958-16Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing LY2599506 with Placebo (2 arms). Primary endpoint: Change in HbA1c from baseline to week 12. Started Nov 2009; status: completed.
02
Drugs
LY2599506
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-014958-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014958-16.